Sang Jun Han

Has grant

Associate Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sang Jun Han is an Associate Professor at Baylor College of Medicine, United States. His research focuses on endometriosis, cancer immunology, and the role of steroid receptor coactivators in tumor biology. Recent publications include studies on endometriosis suppression mechanisms and innovative therapeutic strategies for cancer treatment.

Recent Grants

Grant: Close

The Genomic Function of Estrogen Receptor Beta in Endometriosis

Open Date: 2020-03-06

Close Date: 2024-12-31

Articles (9)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (1)

Jianming Xu

Professor

Baylor College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sang Jun Han

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (9)

N-Myc and STAT Interactor is an Endometriosis Suppressor

Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion

Oleuropein suppresses endometriosis progression and improves the fertility of mice with endometriosis.

Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.

Interferon Signaling in the Endometrium and in Endometriosis

Triphenyl phosphate activates estrogen receptor α/NF-κB/ cyclin D1 signaling to stimulate cell cycle progression in human Ishikawa endometrial cancer cells.

Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis.

A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells.

Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis.

Collaborators (1)

Jianming Xu

Make your next move.